RNFL analysis by OCT... onto the next level for glaucoma diagnosis

Article

Looking at OCT as a sensitive diagnostic test for glaucomatous progression.

Key Points

Standard Automated Perimetry, (SAP) unarguably the gold standard to evaluate glaucomatous neuropathy and to monitor disease progression has poor sensitivity for detecting glaucoma. Quigley and co workers1 showed that significant axonal loss may precede the development of visual field defect and identifiable cupping. Since the test requires subjective input, it is therefore prone to short and long term fluctuation. Subsequently, there is clearly a compelling need for more sensitive glaucoma diagnostic tests.

Available technologies

•The first was a two year study, conducted where RNFL assessment in glaucoma suspects was correlated to Short Wave Automated Perimetry changes.

•The second was over five years and was conducted with 532 eyes where RNFL assessment was correlated to Standard Automated Perimetry changes.

The two-year study, which started with 132 eyes of glaucoma suspects converted to SWAP changes (p<0.01) in an average lead time of 7.6 months with a positive predictive value of 72%.

The five-year study began with 232 eyes of glaucoma suspects which went on to 532 eyes in five years and a statistically significant number (p<0.01) converted to Standard Automated Perimetry changes in an average lead time of 36.2 months with a positive predictive value of 76%

In addition, the locations of the RNFL changes corresponded closely with the regions of the visual field where the defects occurred.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Osamah Saeedi, MD, MS, at ARVO 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
Paul Harasymowycz, MD
Ms Neeru Vallabh on a virtual call with Ophthalmology Times Europe
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Related Content
© 2024 MJH Life Sciences

All rights reserved.